Rejected
at 7:04 p.m. Oct, 31, 2023 ]
by
Alex
Author:
jpk429
Type of change:
Updated content
Rationale for change
Clarification on receptor selectivity
Rejection reason
sitting for over a month, another suggestion resolves this partially
Current
Suggested
Extra
Extra
Extra
Extra
Text
Terazosin is a(n) {{c1::selective α1}} receptor antagonist used to treat benign prostatic hyperplasia (BPH) in patients with {{c2::hypertension}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Additional Resources
Empty field
One by one
Empty field